MétaCan
Menu
Back to cohort

575 Epigenetic modulation by KDM6B in myeloid cells regulates glioblastoma immune checkpoint therapy outcomes

2024· article· en· W4404064334 on OpenAlexaff
Pratishtha Singh, Deblina Raychaudhuri, Yulong Chen, Candice C. Poon, Mercedes Hennessey, Aminah J. Tannir, Sreyashi Basu, Padmanee Sharma, Sangeeta Goswami

Bibliographic record

VenueRegular and Young Investigator Award Abstracts · 2024
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicHistone Deacetylase Inhibitors Research
Canadian institutionsUniversity of Calgary
FundersUniversity of Texas MD Anderson Cancer CenterAndrew Sabin Family Foundation
KeywordsEpigeneticsGlioblastomaCancer researchEpigenetic therapyImmune checkpointImmune systemMedicineDNA methylationImmunotherapyBiologyGeneImmunologyGeneticsGene expression

Abstract

fetched live from OpenAlex

<h3>Background</h3> Glioblastoma (GBM), a disease with a grim overall prognosis, exhibits inherent resistance to immune checkpoint therapy (ICT). GBM tumors notably contain immune-suppressive myeloid cell subsets, which contribute to this resistance. The potential to enhance ICT response by targeting specific epigenetic pathways to reprogram these immune-suppressive myeloid cells into an immune-stimulatory phenotype remains largely unexplored. Our objective was to identify key epigenetic factors that regulate immune-suppressive pathways in myeloid cells and to target these factors to overcome myeloid cell-mediated resistance to ICT in GBM. <h3>Methods</h3> To identify epigenetic factors in intratumoral myeloid cell subsets, we performed scRNA-seq and spatial transcriptomic analysis (Visium) on CD45+ immune cells from GBM patient samples (MD Anderson IRB-approved protocol PA13-029). We investigated the impact of myeloid-specific Kdm6b deletion on the GBM tumor immune microenvironment using scRNA-seq on GBM tumors from control and LysM<sup>cre</sup>KDM6B<sup>fl/fl</sup> mice carrying the Kdm6b deletion in myeloid cells. For mechanistic insights, we conducted scATAC-seq and CHIPseq on CD45+ cells from tumors and bone marrow derived macrophages of mice. To determine the translational relevance of our findings from the genetic model, we compared murine GBM tumor growth and the tumor immune microenvironment in the presence and absence of a pharmacological inhibitor of KDM6B (GSK-J4). <h3>Results</h3> Single-cell and spatial transcriptomic analyses of human GBM tumors revealed that intratumoral immune-suppressive myeloid cell subsets highly express the epigenetic enzyme histone 3 lysine 27 demethylase (KDM6B). Significantly, the deletion of Kdm6b specifically in myeloid cells led to reduced tumor burden and improved survival in preclinical GBM models. Mechanistic studies showed that Kdm6b-deficient myeloid cells had altered epigenetic and transcriptomic profiles, with an increased interferon response, enhanced phagocytic ability, and improved antigen presentation. Additionally, pharmacological inhibition of KDM6B in a murine GBM model replicated the genetic model’s functional phenotype and improved survival following anti-PD1 therapy. <h3>Conclusions</h3> This study identified KDM6B as a key epigenetic regulator of myeloid cell phenotype and function, underscoring its potential as a therapeutic target to improve responses to anti-PD1 therapy. <h3>Acknowledgements</h3> This research is supported by the MD Anderson Physician Scientist Award, Khalifa Physician Scientist Award, Andrew Sabin Family Foundation Fellows Award and Clinic and Laboratory Integration Program Award awarded to Sangeeta Goswami. <h3>Ethics Approval</h3> MD Anderson IRB-approved protocol PA13-029.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.037
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.248
Teacher spread0.240 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueRegular and Young Investigator Award AbstractsSame topicHistone Deacetylase Inhibitors ResearchFrench-language works237,207